Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Conduent
CNDT
$252M
| $15M | ﹤0.01% |
2,414,098
-1,826
| -0.1% | -$11.4K |
|
|
CSR
1927
Centerspace
CSR
$939M
| $15M | ﹤0.01% |
206,248
+495
| +0.2% | +$37K |
|
1928
Flex
FLEX
$45.9B
| $14.9M | ﹤0.01% |
1,566,192
-131,344
| -8% | -$1.13M |
|
1929
Theravance Biopharma
TBPH
$878M
| $14.8M | ﹤0.01% |
571,576
-6,094
| -1% | -$118K |
|
1930
PG&E
PCG
$38.5B
| $14.8M | ﹤0.01% |
1,359,740
+64,552
| +5% | +$553K |
|
1931
Kearny Financial
KRNY
$604M
| $14.8M | ﹤0.01% |
1,068,417
-47,803
| -4% | -$660K |
|
1932
Varex Imaging
VREX
$780M
| $14.7M | ﹤0.01% |
493,625
-23,891
| -5% | -$714K |
|
1933
Vanguard Morningstar Small-Cap ETF
VB
$83.4B
| $14.7M | ﹤0.01% |
88,819
+2,568
| +3% | +$409K |
|
1934
Oil States International
OIS
$526M
| $14.7M | ﹤0.01% |
901,565
-485
| -0.1% | -$7.37K |
|
|
HOUS
1935
DELISTED
Anywhere Real Estate
HOUS
| $14.7M | ﹤0.01% |
1,518,425
-21,052
| -1% | -$193K |
|
|
ZUO
1936
DELISTED
Zuora, Inc.
ZUO
| $14.7M | ﹤0.01% |
1,025,655
-14,239
| -1% | -$209K |
|
|
ORC
1937
Orchid Island Capital
ORC
$1.32B
| $14.7M | ﹤0.01% |
501,790
-8,940
| -2% | -$256K |
|
1938
Herc Holdings
HRI
$5.64B
| $14.7M | ﹤0.01% |
299,547
-2,148
| -0.7% | -$100K |
|
|
CIVI
1939
DELISTED
Civitas Resources
CIVI
| $14.6M | ﹤0.01% |
627,425
+187,182
| +43% | +$3.7M |
|
1940
Inspire Medical Systems
INSP
$1.68B
| $14.6M | ﹤0.01% |
196,941
-3,321
| -2% | -$213K |
|
|
CSW
1941
CSW Industrials
CSW
$5.59B
| $14.6M | ﹤0.01% |
189,349
-5,498
| -3% | -$395K |
|
1942
ArcelorMittal
MT
$55.2B
| $14.6M | ﹤0.01% |
830,729
+21,165
| +3% | +$343K |
|
|
CKH
1943
DELISTED
Seacor Holdings Inc.
CKH
| $14.6M | ﹤0.01% |
337,612
-4,585
| -1% | -$200K |
|
1944
Trupanion
TRUP
$1.36B
| $14.6M | ﹤0.01% |
388,817
-9,647
| -2% | -$283K |
|
1945
Enanta Pharmaceuticals
ENTA
$391M
| $14.5M | ﹤0.01% |
234,298
-7,349
| -3% | -$456K |
|
1946
AMC Global Media
AMCX
$496M
| $14.4M | ﹤0.01% |
365,787
-61,207
| -14% | -$2.57M |
|
|
PDLI
1947
DELISTED
PDL BioPharma, Inc.
PDLI
| $14.3M | ﹤0.01% |
4,417,472
-63,101
| -1% | -$183K |
|
1948
Green Plains
GPRE
$1.09B
| $14.3M | ﹤0.01% |
928,003
-32,042
| -3% | -$436K |
|
1949
ArcBest
ARCB
$3.28B
| $14.3M | ﹤0.01% |
517,894
-10,190
| -2% | -$295K |
|
1950
Deutsche Bank
DB
$72.1B
| $14.3M | ﹤0.01% |
1,835,991
-206,940
| -10% | -$1.55M |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.